BIOSPECIFICS TECHNOLOGIES CORP Deferred Costs, Current
BIOSPECIFICS TECHNOLOGIES CORP had Deferred Costs, Current of $601.66 thousand as of 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredCostsCurrent · last filed 2018-11-09
- 2018-09-30: Deferred Costs, Current $601.66K.
- 2018-06-30: Deferred Costs, Current $1.12M.
- 2018-03-31: Deferred Costs, Current $1.65M.
- 2017-12-31: Deferred Costs, Current $1.79M.
| Period end | Deferred Costs, Current |
|---|---|
| 2018-09-30 | $601.66K 10-Q · filed 2018-11-09 |
| 2018-06-30 | $1.12M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.65M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $1.79M 10-Q · filed 2018-11-09 |
| 2017-09-30 | $1.57M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $1.54M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $1.49M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $1.45M 10-K · filed 2018-03-14 |
| 2016-09-30 | $1.22M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $1.14M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.18M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $1.02M 10-K · filed 2017-03-16 |
| 2015-09-30 | $802.09K 10-Q · filed 2015-11-09 |
| 2015-06-30 | $640.59K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $628.72K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $569.64K 10-K · filed 2016-03-14 |
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 |